Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25. https://doi.org/10.1016/j.fertnstert.2003.10.004

Article  Google Scholar 

Conway G, Dewailly D, Diamanti-Kandarakis E et al (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171:P1–P29. https://doi.org/10.1530/EJE-14-0253

Article  CAS  PubMed  Google Scholar 

Stevanovic D, Bozic-Antic I, Stanojlovic O et al (2019) Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): a psychometric study with the Serbian version. Women Health 59:1015–1025. https://doi.org/10.1080/03630242.2019.1587664

Article  PubMed  Google Scholar 

Patel S (2018) Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol 182:27–36. https://doi.org/10.1016/j.jsbmb.2018.04.008

Article  CAS  PubMed  Google Scholar 

Panidis D, Tziomalos K, Misichronis G et al (2012) Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod 27:541–549. https://doi.org/10.1093/humrep/der418

Article  CAS  PubMed  Google Scholar 

Panidis D, Macut D, Tziomalos K et al (2013) Prevalence of metabolic syndrome in women with polycystic ovary syndrome. Clin Endocrinol 78:586–592. https://doi.org/10.1111/cen.12008

Article  Google Scholar 

Macut D, Tziomalos K, Božić-Antić I et al (2016) Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. Hum Reprod 31:1347–1353. https://doi.org/10.1093/humrep/dew076

Article  CAS  PubMed  Google Scholar 

Macut D, Bjekić-Macut J, Rahelić D, Doknić M (2017) Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pract 130:163–170. https://doi.org/10.1016/j.diabres.2017.06.011

Article  CAS  PubMed  Google Scholar 

Soldat-Stanković V, Popović-Pejičić S, Stanković S et al (2022) The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. J Endocrinol Investig 45:583–595. https://doi.org/10.1007/s40618-021-01691-5

Article  CAS  Google Scholar 

Homburg R (2004) Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:773–788. https://doi.org/10.1016/j.bpobgyn.2004.05.006

Article  PubMed  Google Scholar 

Balen AH, Rutherford AJ (2007) Managing anovulatory infertility and polycystic ovary syndrome. BMJ 335:663–666. https://doi.org/10.1136/bmj.39335.462303.80

Article  PubMed  PubMed Central  Google Scholar 

Gadalla MA, Norman RJ, Tay CT et al (2020) Medical and surgical treatment of reproductive outcomes in polycystic ovary syndrome: an overview of systematic reviews. Int J Fertil Steril 13:257–270. https://doi.org/10.22074/ijfs.2020.5608

Article  PubMed  Google Scholar 

Diamanti-Kandarakis E (2012) Infertility treatment in PCOS—is metformin in from the cold? Nat Rev Endocrinol 8:328–330. https://doi.org/10.1038/nrendo.2012.69

Article  PubMed  Google Scholar 

Tsiami AP, Goulis DG, Sotiriadis AI, Kolibianakis EM (2021) Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis. Hormones (Athens) 20:449–461. https://doi.org/10.1007/s42000-021-00289-z

Article  PubMed  Google Scholar 

Moghetti P, Tosi F (2021) Insulin resistance and PCOS: chicken or egg? J Endocrinol Investig 44:233–244. https://doi.org/10.1007/s40618-020-01351-0

Article  CAS  Google Scholar 

Fleming R (2006) The use of insulin sensitising agents in ovulation induction in women with Polycystic Ovary Syndrome. Hormones (Athens) 5:171–178. https://doi.org/10.14310/horm.2002.11181

Article  PubMed  Google Scholar 

Dunaif A, Thomas A (2001) Current concepts in the polycystic ovary syndrome. Annu Rev Med 52:401–419. https://doi.org/10.1146/annurev.med.52.1.401

Article  CAS  PubMed  Google Scholar 

Kim JY, Tfayli H, Michaliszyn SF, Arslanian S (2018) Impaired lipolysis, diminished fat oxidation, and metabolic inflexibility in obese girls with polycystic ovary syndrome. J Clin Endocrinol Metab 103:546–554. https://doi.org/10.1210/jc.2017-01958

Article  PubMed  Google Scholar 

Rudnicka E, Suchta K, Grymowicz M et al (2021) Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci 22:3789. https://doi.org/10.3390/ijms22073789

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown J, Farquhar C, Beck J et al (2009) Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev 4:CD002249. https://doi.org/10.1002/14651858.CD002249.pub4

Article  Google Scholar 

Vatier C, Christin-Maitre S, Vigouroux C (2022) Role of insulin resistance on fertility – focus on polycystic ovary syndrome. Ann Endocrinol (Paris) 83:199–202. https://doi.org/10.1016/j.ando.2022.04.004

Article  PubMed  Google Scholar 

Liu Y, Li J, Yan Z et al (2021) Improvement of insulin sensitivity increases pregnancy rate in infertile PCOS women: a systemic review. Front Endocrinol (Lausanne) 12:657889

Article  PubMed  Google Scholar 

Dunaif A, Segal KR, Shelley DR et al (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257–1266. https://doi.org/10.2337/diab.41.10.1257

Article  CAS  PubMed  Google Scholar 

Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98:2133–2223. https://doi.org/10.1152/physrev.00063.2017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diamanti-Kandarakis E, Papavassiliou AG (2006) Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 12:324–332. https://doi.org/10.1016/j.molmed.2006.05.006

Article  CAS  PubMed  Google Scholar 

Tremellen K, Pearce K (2012) Dysbiosis of gut microbiota (DOGMA) – a novel theory for the development of polycystic ovarian syndrome. Med Hypotheses 79:104–112. https://doi.org/10.1016/j.mehy.2012.04.016

Article  PubMed  Google Scholar 

Parker J, O’Brien C, Hawrelak J (2022) A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome. Obstet Gynecol Sci 65:14–28. https://doi.org/10.5468/ogs.21185

Article  PubMed  PubMed Central  Google Scholar 

Penzias A, Bendikson K, Butts S et al (2017) Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil Steril 108:426–441. https://doi.org/10.1016/j.fertnstert.2017.06.026

Article  CAS  Google Scholar 

Palomba S, Falbo A, Russo T et al (2010) Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response. Hum Reprod 25:1005–1013. https://doi.org/10.1093/humrep/dep466

Article  CAS  PubMed  Google Scholar 

Rice S, Elia A, Jawad Z et al (2013) Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab 98:E1491–E1500. https://doi.org/10.1210/jc.2013-1865

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan L, Wu H, Huang W et al (2021) The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis. Reprod Biol Endocrinol 19:89. https://doi.org/10.1186/s12958-021-00772-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishihara S, Fukuda J, Ezoe K et al (2020) Does the endometrial thickness on the day of the trigger affect the pregnancy outcomes after fresh cleaved embryo transfer in the clomiphene citrate-based minimal stimulation cycle? Reprod Med Biol 19:151–157. https://doi.org/10.1002/rmb2.12315

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chi RA, Wang T, Adams N et al (2020) Human endometrial transcriptome and progesterone receptor cistrome reveal important pathways and epithelial regulators. J Clin Endocrinol Metab 105:e1419–e1439. https://doi.org/10.1210/clinem/dgz117

Article  PubMed  Google Scholar 

Hu M, Zhang Y, Li X et al (2020) Alterations of endometrial epithelial–mesenchymal transition and MAPK signalling components in women with PCOS are partially modulated by metformin in vitro. Mol Hum Reprod 26:312–326. https://doi.org/10.1093/molehr/gaaa023

Article  CAS  PubMed  Google Scholar 

Hu M, Zhang Y, Li X et al (2021) TLR4-associated IRF-7 and NFκB signaling act as a molecular link between androgen and metformin activities and cytokine synthesis in the PCOS endometrium. J Clin Endocrinol Metab 106:e1022–e1040. https://doi.org/10.1210/clinem/dgaa951

Article  Google Scholar